Innate Pharma IPHA
NASDAQ IPHA
$1.59 +0.05 (+3.25%)
As of: Nov 11, 2026 · 3:56 PM EST

Innate Pharma (IPHA) Goodwill impairment charges (2019 - 2025)

Updated

Innate Pharma's Goodwill impairment charges came in at -$62.87 million for the quarter ended Dec 31, 2025, compared with -$55.11 million a year earlier.

Analysis

Innate Pharma (IPHA) Goodwill impairment charges (2019 - 2025) Analysis & Trends

Over the trailing twelve months to Dec 31, 2025, Innate Pharma reported Goodwill impairment charges of -$190.2 million; for the year ended Dec 31, 2022, it was -$43.21 million.

  • Going back by year, Goodwill impairment charges was -$29.94 million in the year ended Dec 31, 2019.
  • The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Goodwill impairment charges since the quarter ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Innate Pharma 142.45 Mn -64.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -62.87 Mn
Dec 31, 2024 -55.11 Mn
Dec 31, 2023 -13.63 Mn
Dec 31, 2022 -58.59 Mn
Dec 31, 2021 -54.71 Mn
Dec 31, 2020 -74.01 Mn
Dec 31, 2019 -29.94 Mn
API Access

Innate Pharma Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=IPHA&period=max&api_key=YOUR_API_KEY